文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Mechanism of action of the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome and its regulation in liver injury.

作者信息

Lu Yifan, Wang Tianyu, Yu Bo, Xia Kang, Guo Jiayu, Liu Yiting, Ma Xiaoxiong, Zhang Long, Zou Jilin, Chen Zhongbao, Zhou Jiangqiao, Qiu Tao

机构信息

Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

出版信息

Chin Med J (Engl). 2025 May 5;138(9):1061-1071. doi: 10.1097/CM9.0000000000003309. Epub 2024 Dec 23.


DOI:10.1097/CM9.0000000000003309
PMID:39719693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12068774/
Abstract

Nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) is a cytosolic pattern recognition receptor that recognizes multiple pathogen-associated molecular patterns and damage-associated molecular patterns. It is a cytoplasmic immune factor that responds to cellular stress signals, and it is usually activated after infection or inflammation, forming an NLRP3 inflammasome to protect the body. Aberrant NLRP3 inflammasome activation is reportedly associated with some inflammatory diseases and metabolic diseases. Recently, there have been mounting indications that NLRP3 inflammasomes play an important role in liver injuries caused by a variety of diseases, specifically hepatic ischemia/reperfusion injury, hepatitis, and liver failure. Herein, we summarize new research pertaining to NLRP3 inflammasomes in hepatic injury, hepatitis, and liver failure. The review addresses the potential mechanisms of action of the NLRP3 inflammasome, and its regulation in these liver diseases.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/12068774/e4a138c36a0d/cm9-138-1061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/12068774/608ba71b5a47/cm9-138-1061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/12068774/e4a138c36a0d/cm9-138-1061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/12068774/608ba71b5a47/cm9-138-1061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/12068774/e4a138c36a0d/cm9-138-1061-g002.jpg

相似文献

[1]
Mechanism of action of the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome and its regulation in liver injury.

Chin Med J (Engl). 2025-5-5

[2]
Liver kinase B1 attenuates liver ischemia/reperfusion injury via inhibiting the NLRP3 inflammasome.

Acta Biochim Biophys Sin (Shanghai). 2021-4-15

[3]
NLRP3 Is Involved in Ischemia/Reperfusion Injury.

CNS Neurol Disord Drug Targets. 2016

[4]
Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury.

Pharmacol Res. 2021-2

[5]
Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.

Immunol Invest. 2023-4

[6]
Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.

Mol Neurobiol. 2016-7

[7]
NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis.

J Pathol. 2017-7

[8]
Down-regulation of TRPM2 attenuates hepatic ischemia/reperfusion injury through activation of autophagy and inhibition of NLRP3 inflammasome pathway.

Int Immunopharmacol. 2022-3

[9]
Bruton's Tyrosine Kinase Inhibitor Attenuates Warm Hepatic Ischemia/Reperfusion Injury via Modulation of the NLR Family Pyrin Domain Containing 3 Inflammasome.

Transplant Proc. 2020-12

[10]
NLRP3: Role in ischemia/reperfusion injuries.

Front Immunol. 2022

引用本文的文献

[1]
Prevalence and risk factors of chronic postsurgical pain after lung cancer surgery and knee arthroplasty: a prospective multicenter cohort study in Japan.

J Anesth. 2025-4-13

[2]
Comparison of the clinical efficacy of lateral versus medial unicondylar replacement for unicompartmental osteoarthritis of the knee: a meta-analysis.

J Orthop Surg Res. 2025-1-4

本文引用的文献

[1]
Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation.

J Clin Invest. 2023-10-16

[2]
NASH drug treatment development: challenges and lessons.

Lancet Gastroenterol Hepatol. 2023-10

[3]
Ghrelin protects against ischemia/reperfusion-induced hepatic injury via inhibiting Caspase-11-mediated noncanonical pyroptosis.

Transpl Immunol. 2023-10

[4]
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers.

Clin Transl Sci. 2023-9

[5]
Inhibition of macrophages inflammasome activation autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis.

Front Immunol. 2023

[6]
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation.

Int J Mol Sci. 2023-3-24

[7]
Global burden of liver disease: 2023 update.

J Hepatol. 2023-8

[8]
NLRP3 Inflammasome: A key contributor to the inflammation formation.

Food Chem Toxicol. 2023-4

[9]
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors.

Front Immunol. 2022

[10]
Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis/hepatitis B - induced hepatic injury.

Clin Res Hepatol Gastroenterol. 2023-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索